A comparison of urinary albumin excretion rate and microalbuminuria in various glucose tolerance subjects
Authors:
- 16 February 2005
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 22 (3) , 332-335
Abstract
Aims To investigate the difference of urinary albumin excretion rate (UAER) and microalbuminuria (MAU) in various glucose tolerance subjects, especially between isolated‐impaired glucose tolerance subjects and isolated‐impaired fasting glycaemia subjects.Methods A total of 2934 subjects were divided into five groups with various glucose tolerances, based on a 75‐g oral glucose tolerance test. Microalbuminuria was defined when urinary albumin excretion rate was between 20 and 200 µg/min.Results (i) The UAER in the newly diagnosed Type 2 diabetes mellitus group, impaired glucose tolerance/impaired fasting glycaemia group and isolated‐impaired glucose tolerance group were all higher than that in the isolated‐impaired fasting glycaemia group and normal glucose tolerance group, but it was comparable between isolated‐impaired fasting glycemia group and normal glucose tolerance group. The prevalence of MAU and the odds ratio for MAU with adjustment for age and sex in various glucose tolerance groups showed the same trend as the UAER. (ii) After adjusting for age and sex, there is a significant association between logUAER and independent risk factors (partial correlation coefficients: r = 0.26 for 2‐h post‐challenge blood glucose, r = 0.26 for systolic blood pressure, r = 0.27 for diastolic blood pressure, r = 0.27 for body mass index and r = −0.13 for high density lipoprotein‐cholesterol, all P < 0.001). The risks for MAU were 2‐h post‐challenge blood glucose, body mass index and diastolic blood pressure, while high density lipoprotein‐cholesterol was protective.Conclusions The urinary albumin excretion rate and prevalence of microalbuminuria were higher in isolated‐impaired glucose tolerance subjects than those in isolated‐impaired fasting glycaemia subjects. At early abnormal glucose tolerance stage, the increasing post‐challenge glycaemia might be a more important risk factor for urinary albumin excretion rate and microalbuminuria than increasing fasting glycaemia.Keywords
This publication has 20 references indexed in Scilit:
- Effect of Losartan on Microalbuminuria in Normotensive Patients with Type 2 Diabetes MellitusAnnals of Internal Medicine, 2003
- Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 DiabetesNew England Journal of Medicine, 2003
- Rosiglitazone reduces urinary albumin excretion in type II diabetesJournal of Human Hypertension, 2003
- Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and interventionDiabetic Medicine, 2002
- Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokesKidney International, 2002
- Disturbances in β-Cell Function in Impaired Fasting GlycemiaDiabetes, 2002
- Rapid Progression of Albumin Excretion Is an Independent Predictor of Cardiovascular Mortality in Patients With Type 2 Diabetes and MicroalbuminuriaDiabetes Care, 2001
- Role of Blood Pressure in the Progression of Microalbuminuria in Elderly Japanese Type 2 Diabetic Patients: A 7-Year Follow-up StudyJournal of International Medical Research, 2001
- Risk factors for microalbuminuria in black americans with newly diagnosed type 2 diabetesAmerican Journal of Kidney Diseases, 2000
- Urinary Albumin Excretion as a Predictor of Diabetic Retinopathy, Neuropathy, and Cardiovascular Disease in NIDDMDiabetes Care, 1996